Research desks at Cnbc Awaaz and 2 other desks backed 5 stocks for short-term gains over the coming weeks, reflecting a broadly bullish market view.
Cnbc Awaaz and 2 other registered desks issued 183 equity short term recommendations today, targeting gains over a 2 to 4 week horizon. The batch carries a broadly bullish bias — 177 buys against 6 sells — covering 5 stocks.
STARHEALTH attracted 43 separate recommendations from registered analysts — Cnbc Awaaz issued a buy at ₹604.55 targeting ₹710; Cnbc Awaaz issued a buy at ₹604.55 targeting ₹700; Cnbc Awaaz issued a buy at ₹611.6 targeting ₹700; Cnbc Awaaz issued a buy at ₹611.6 targeting ₹710; Cnbc Awaaz issued a buy at ₹614.45 targeting ₹700; Cnbc Awaaz issued a buy at ₹614.45 targeting ₹710; Cnbc Awaaz issued a buy at ₹620.2 targeting ₹710; Cnbc Awaaz issued a buy at ₹620.2 targeting ₹700; Cnbc Awaaz issued a buy at ₹612.55 targeting ₹710; Cnbc Awaaz issued a buy at ₹612.05 targeting ₹700; Cnbc Awaaz issued a buy at ₹611.05 targeting ₹700; Cnbc Awaaz issued a buy at ₹611.05 targeting ₹710; Cnbc Awaaz issued a buy at ₹607.85 targeting ₹700; Cnbc Awaaz issued a buy at ₹607.95 targeting ₹700; Cnbc Awaaz issued a buy at ₹605.15 targeting ₹710; Cnbc Awaaz issued a buy at ₹605.15 targeting ₹700; Cnbc Awaaz issued a buy at ₹605.45 targeting ₹700; Cnbc Awaaz issued a buy at ₹605.45 targeting ₹710; Cnbc Awaaz issued a buy at ₹604.25 targeting ₹710; Cnbc Awaaz issued a buy at ₹604.25 targeting ₹700; Cnbc Awaaz issued a buy at ₹607.85 targeting ₹710; Cnbc Awaaz issued a buy at ₹608.15 targeting ₹700; Cnbc Awaaz issued a buy at ₹603 targeting ₹710; Cnbc Awaaz issued a buy at ₹603 targeting ₹700; Cnbc Awaaz issued a buy at ₹604.35 targeting ₹710; Cnbc Awaaz issued a buy at ₹604.35 targeting ₹700; Cnbc Awaaz issued a buy at ₹604.8 targeting ₹710; Cnbc Awaaz issued a buy at ₹604.8 targeting ₹700; Cnbc Awaaz issued a buy at ₹606.7 targeting ₹710; Cnbc Awaaz issued a buy at ₹606.7 targeting ₹700; Cnbc Awaaz issued a buy at ₹607.5 targeting ₹700; Cnbc Awaaz issued a buy at ₹607.7 targeting ₹710; Cnbc Awaaz issued a buy at ₹603.4 targeting ₹710; Cnbc Awaaz issued a buy at ₹603.4 targeting ₹700; Cnbc Awaaz issued a buy at ₹602.15 targeting ₹700; Cnbc Awaaz issued a buy at ₹602.15 targeting ₹710; Cnbc Awaaz issued a buy at ₹602.5 targeting ₹710; Cnbc Awaaz issued a buy at ₹605.65 targeting ₹710; Cnbc Awaaz issued a buy at ₹605.65 targeting ₹700; Zee Business issued a buy at ₹598 targeting ₹700; Zee Business issued a buy at ₹598.85 targeting ₹609 (stop ₹593); Cnbc Awaaz issued a buy at ₹598.85 targeting ₹710; Cnbc Awaaz issued a buy at ₹598.85 targeting ₹700.
COLPAL attracted 43 separate recommendations from registered analysts — Cnbc Awaaz issued a buy at ₹2,082.3 targeting ₹2,650; Cnbc Awaaz issued a buy at ₹2,082.1 targeting ₹2,550; Cnbc Awaaz issued a buy at ₹2,082.1 targeting ₹2,140; Cnbc Awaaz issued a buy at ₹2,086 targeting ₹2,650; Cnbc Awaaz issued a buy at ₹2,086 targeting ₹2,550; Cnbc Awaaz issued a buy at ₹2,086 targeting ₹2,140; Cnbc Awaaz issued a buy at ₹2,094.2 targeting ₹2,650; Cnbc Awaaz issued a buy at ₹2,094.6 targeting ₹2,650; Cnbc Awaaz issued a buy at ₹2,089 targeting ₹2,650; Cnbc Awaaz issued a buy at ₹2,089 targeting ₹2,140; Cnbc Awaaz issued a buy at ₹2,089 targeting ₹2,550; Cnbc Awaaz issued a buy at ₹2,101.7 targeting ₹2,650; Cnbc Awaaz issued a buy at ₹2,101.7 targeting ₹2,140; Cnbc Awaaz issued a buy at ₹2,101.7 targeting ₹2,550; Cnbc Awaaz issued a buy at ₹2,103 targeting ₹2,140; Cnbc Awaaz issued a buy at ₹2,103 targeting ₹2,550; Cnbc Awaaz issued a buy at ₹2,103 targeting ₹2,650; Cnbc Awaaz issued a buy at ₹2,100.6 targeting ₹214; Cnbc Awaaz issued a buy at ₹2,102.1 targeting ₹2,650; Cnbc Awaaz issued a buy at ₹2,102.1 targeting ₹2,550; Cnbc Awaaz issued a buy at ₹2,102.1 targeting ₹2,140; Cnbc Awaaz issued a buy at ₹2,099 targeting ₹2,650; Cnbc Awaaz issued a buy at ₹2,100.8 targeting ₹2,550; Cnbc Awaaz issued a buy at ₹2,100.1 targeting ₹2,140; Cnbc Awaaz issued a buy at ₹2,102 targeting ₹2,650; Cnbc Awaaz issued a buy at ₹2,102 targeting ₹2,550; Cnbc Awaaz issued a buy at ₹2,102 targeting ₹2,140; Cnbc Awaaz issued a buy at ₹2,095.5 targeting ₹2,650; Cnbc Awaaz issued a buy at ₹2,096.9 targeting ₹2,550; Cnbc Awaaz issued a buy at ₹2,096.9 targeting ₹2,140; Cnbc Awaaz issued a buy at ₹2,110.3 targeting ₹2,650; Cnbc Awaaz issued a buy at ₹2,110.3 targeting ₹2,550; Cnbc Awaaz issued a buy at ₹2,111.4 targeting ₹2,140; Cnbc Awaaz issued a buy at ₹2,137.3 targeting ₹2,650; Cnbc Awaaz issued a buy at ₹2,137.3 targeting ₹2,550; Cnbc Awaaz issued a buy at ₹2,137.3 targeting ₹2,140; Ndtv Profit issued a buy at ₹2,145 targeting ₹2,650; Ndtv Profit issued a sell at ₹2,166 targeting ₹2,050; Ndtv Profit issued a sell at ₹2,166 targeting ₹2,000; Cnbc Awaaz issued a buy at ₹2,166.4 targeting ₹2,650; Cnbc Awaaz issued a buy at ₹2,166.4 targeting ₹2,550; Cnbc Awaaz issued a buy at ₹2,166 targeting ₹2,550; Cnbc Awaaz issued a buy at ₹2,166 targeting ₹2,140.
NYKAA attracted 2 separate recommendations from registered analysts — Cnbc Awaaz issued a buy at ₹333 targeting ₹760 (stop ₹745); Cnbc Awaaz issued a buy at ₹332 targeting ₹355 (stop ₹323).
Also covered: ASIANPAINT (₹2,739 → ₹3,750) via Cnbc Awaaz, Ndtv Profit, Zee Business; BAJAJFINSV (₹1,906.3 → ₹1,960) via Zee Business.
Short-term calls are designed to play out over two to four weeks. Quarterly results, FII flows, and sector rotation remain key variables during the holding period.
All recommendations reproduced here originate exclusively from SEBI-registered Research Analysts and are published for informational purposes only. These are not buy or sell recommendations from this publication. Registration with SEBI does not guarantee returns. Investing in securities markets is subject to market risks — read all related documents carefully before investing.
Disclaimer
All recommendations published on Bharatstox are sourced exclusively from SEBI-registered Research Analysts. Registration with SEBI does not guarantee returns or the performance of the intermediary. Investing in securities markets is subject to market risks. Read all related documents carefully before investing. This article is for informational purposes only and does not constitute investment advice.